Loading
AT
Aratana Therapeutics, Inc. Stock: price and insider trades · United States
Aratana Therapeutics, Inc.: what insiders have been doing
Only a handful of insider records exist for Aratana Therapeutics, Inc., the last one from 2 February 2016, too few to describe a trend. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
1 ops. · all time
Last declaration on 2 February 2016
Declarations5 total
2,806 sharesCOMMON STOCKSEC:0001209191-16-095025:0
43,000 sharesCommon StockSEC:0001209191-16-093674:0
97,500 sharesCommon StockSEC:0001209191-16-093675:0
27,500 sharesCommon StockSEC:0001209191-16-093676:0
35,250 sharesCommon StockSEC:0001209191-16-093677:0
5 of 5 declarations
About Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutic products for companion animals. The company is listed on NASDAQ under the ticker symbol PETX.
